Three decades of landmark research into type 2 diabetes prevention abruptly ended this month due to government funding cuts. The Endocrine Society calls on the administration to restore the Diabetes Prevention Program (DPP) and DPP Outcomes Study funded through the National Institutes of Health. The Society is concerned about how the loss of this ongoing...
On March 18, Queen’s University in Kington, Ontario, Canada, announced that Lisa Tannock, MD, was appointed dean, Queen’s Health Sciences, and director of the School Medicine, effective July 1. Tannock will join Queen’s University from the University of Kentucky, where she is associate provost for faculty advancement and a professor in the Division of Endocrinology,...
A third generation of the latest cholesterol-lowering medication — PCSK9-inhibitors — will soon be available for patients with homozygous familial hypercholesterolemia (HoFH), according to a January 24 article in The Lancet Diabetes & Endocrinology. Affecting approximately 30,000 individuals worldwide, HoFH is a rare but serious genetic disorder in which patients have markedly elevated levels (>10...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer new possibilities for long-term weight management, according to a recent review article published in Endocrinology. Authors Lauren A. Jones and Daniel I. Brierley, PhD, both of the Centre for Cardiovascular...
On March 13, the Board of Trustees of the University of Pennsylvania voted unanimously to appoint Endocrine Society Past-President J. Larry Jameson, MD, PhD, who has served as interim president since December 2023, president of the University for a term that will run through June 30, 2027. In announcing the appointment, Chair of the Board...
Endocrine Society members elected Nanette Santoro, MD (left) of the University of Colorado School of Medicine in Aurora, Colo., as its 2026-2027 President. She will serve as President-Elect for a year beginning in July 2025 before becoming President in June 2026. Santoro has served as E. Stewart Taylor Chair of Obstetrics & Gynecology at the...
The Endocrine Society offers many things to our thousands of members: continuing education, clinical guidelines, scientific statements, advocacy campaigns, networking groups, career development, awards recognition, and leadership opportunities, to name a few. But the Society’s biggest and most visible offering by far is ENDO! This year’s ENDO 2025 in San Francisco, Calif., July 12-15, promises...
Leading pediatric endocrinologist and recipient of the Endocrine Society’s 2025 Outstanding Leadership in Endocrinology Laureate Award, Ilene Fennoy, MD, talks with Endocrine News about the potential of GLP-1s and long-term solutions for childhood obesity. She says a good place to start is creating more programs in schools to help kids eat better and incorporate more...
On March 13, the Board of Trustees of the University of Pennsylvania voted unanimously to appoint Endocrine Society Past-President J. Larry Jameson, MD, PhD, who has served as interim president since December 2023, president of the University for a term that will run through June 30, 2027. In announcing the appointment, Chair of the Board...
The Endocrine Society offers many things to our thousands of members: continuing education, clinical guidelines, scientific statements, advocacy campaigns, networking groups, career development, awards recognition, and leadership opportunities, to name a few. But the Society’s biggest and most visible offering by far is ENDO! This year’s ENDO 2025 in San Francisco, Calif., July 12-15, promises...
